An open labelled non-randomized phase II clinical trial to evaluate the efficacy of KARASEELAI an external therapy in the management of VIRANAM (skin ulcer)
Phase 2
- Conditions
- Health Condition 1: L984- Non-pressure chronic ulcer of skin, not elsewhere classified
- Registration Number
- CTRI/2023/05/053018
- Lead Sponsor
- Dr R Supriya
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Acute and chronic ulcers
2.Patient who are willing for admission and stay in IPD or willing to attend OPD
3.Patient who are willing to give blood samples for laboratory investigations
Exclusion Criteria
1.Pregnant and lactating women
2.Severe renal,hepatic,cardiac disease
3.Malignant ulcers
4.Uncontrolled diabetes
5.Syphilitic ulcers
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Pain decreased and healing of the ulcer expectedTimepoint: 15 days
- Secondary Outcome Measures
Name Time Method ILTimepoint: NI